News

‘Tesla CEO Elon Musk Just Had His First Margin Call for Twitter Loan’ -Barron’s Report

https://www.barrons.com/articles/tesla-elon-musk-margin-call-twitter-loan-51672328580?mod=RTA

byBenzinga Newsdesk

December 29, 2022

1 minute read

https://www.barrons.com/articles/tesla-elon-musk-margin-call-twitter-loan-51672328580?mod=RTA

Morgan Stanley Maintains Overweight on Microsoft, Raises Price Target to $331

By vishwanath@benzinga.com

September 14, 8:12 AM

Morgan Stanley analyst Keith Weiss maintains Microsoft (NASDAQ:MSFT) with a Overweight and raises the price target from $305 to $331.

MSFT

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

By Shanthi Rexaline

July 25, 9:26 AM

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

ABBV

Credit Suisse Upgrades ArcelorMittal to Outperform, Raises Price Target to $42

By Benzinga Newsdesk

October 14, 4:53 AM

Credit Suisse analyst Carsten Riek upgrades ArcelorMittal (NYSE:MT) from Neutral to Outperform and raises the price target from $34 to $42.

$1000 Invested In Synopsys 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights

August 16, 3:43 PM

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 5 years by 25.55% on an annualized basis producing an average annual return of 37.58%. Currently, Synopsys has a market capitalization of $58.79 billion.

SNPS

‘Tesla CEO Elon Musk Just Had His First Margin Call for Twitter Loan’ -Barron’s Report

Related Posts

Morgan Stanley Maintains Overweight on Microsoft, Raises Price Target to $331

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

Credit Suisse Upgrades ArcelorMittal to Outperform, Raises Price Target to $42

$1000 Invested In Synopsys 5 Years Ago Would Be Worth This Much Today